BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19168600)

  • 1. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
    Debono M; Ross RJ; Newell-Price J
    Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is physiological glucocorticoid replacement important in children?
    Porter J; Blair J; Ross RJ
    Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
    Johannsson G; Falorni A; Skrtic S; Lennernäs H; Quinkler M; Monson JP; Stewart PM
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):2-11. PubMed ID: 25187037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
    Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
    BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modified-release hydrocortisone for glucocorticoid deficiency].
    Nowotny H; Reisch N
    Internist (Berl); 2020 Jun; 61(6):565-572. PubMed ID: 32394073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
    Debono M; Ross RJ
    Clin Endocrinol (Oxf); 2013 May; 78(5):659-64. PubMed ID: 23194144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal glucocorticoid therapy.
    Debono M; Ross RJ
    Endocr Dev; 2011; 20():173-180. PubMed ID: 21164270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why is the management of glucocorticoid deficiency still controversial: a review of the literature.
    Crown A; Lightman S
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):483-92. PubMed ID: 16268798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doses and steroids to be used in primary and central hypoadrenalism.
    Debono M; Ross RJ
    Ann Endocrinol (Paris); 2007 Sep; 68(4):265-7. PubMed ID: 17651687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology.
    Guarnotta V; Amodei R; Giordano C
    Curr Opin Pharmacol; 2021 Oct; 60():123-132. PubMed ID: 34416524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future treatment options for adrenal insufficiency.
    Arshad MF; Debono M
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):303-311. PubMed ID: 33782339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.